Enzon Pharmaceuticals Statistics
Total Valuation
ENZND has a market cap or net worth of 38.70 million. The enterprise value is 40.73 million.
| Market Cap | 38.70M |
| Enterprise Value | 40.73M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ENZND has 6.45 million shares outstanding.
| Current Share Class | 6.45M |
| Shares Outstanding | 6.45M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 208.18% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.36 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 58.57
| Current Ratio | 58.57 |
| Quick Ratio | 58.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.79% and return on invested capital (ROIC) is -1.94%.
| Return on Equity (ROE) | -7.79% |
| Return on Assets (ROA) | -1.88% |
| Return on Invested Capital (ROIC) | -1.94% |
| Return on Capital Employed (ROCE) | -3.22% |
| Weighted Average Cost of Capital (WACC) | 4.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.53M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENZND has paid 19,000 in taxes.
| Income Tax | 19,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.02% in the last 52 weeks. The beta is 0.08, so ENZND's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -51.02% |
| 50-Day Moving Average | 6.07 |
| 200-Day Moving Average | 6.87 |
| Relative Strength Index (RSI) | 51.09 |
| Average Volume (20 Days) | 800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.36M |
| Pretax Income | -3.39M |
| Net Income | -5.53M |
| EBITDA | n/a |
| EBIT | -1.36M |
| Earnings Per Share (EPS) | -7.46 |
Balance Sheet
The company has 42.57 million in cash and n/a in debt, with a net cash position of 42.57 million or 6.60 per share.
| Cash & Cash Equivalents | 42.57M |
| Total Debt | n/a |
| Net Cash | 42.57M |
| Net Cash Per Share | 6.60 |
| Equity (Book Value) | 42.08M |
| Book Value Per Share | -3.40 |
| Working Capital | 42.08M |
Cash Flow
| Operating Cash Flow | -3.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENZND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -14.30% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 25, 2026. It was a reverse split with a ratio of 0.01.
| Last Split Date | Mar 25, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |